Overview

45th Multicenter Airway Research Collaboration

Status:
NOT_YET_RECRUITING
Trial end date:
2026-06-01
Target enrollment:
Participant gender:
Summary
The study is a randomized controlled trial on the effect of emergency department initiation of Airsupra on acute asthma "recurrence" at 3 months and other related outcomes (acute asthma relapse, asthma control).
Phase:
PHASE4
Details
Lead Sponsor:
Massachusetts General Hospital